ArticleClinics in orthopedic surgery2026
Impact of In-Hospital Osteoporosis Treatment on Post-discharge Medication Continuity in Osteoporotic Fracture Patients: Implications for Care Continuity.
Article in Clinics in orthopedic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite the well-established benefits of osteoporosis medication in reducing the risk of secondary fractures and mortality, post-fracture treatment rates remain suboptimal. The hospitalization period represents a critical opportunity to initiate therapy, yet the impact of in-hospital osteoporosis treatment on long-term adherence has not been fully evaluated in the Korean population. Methods: This retrospective cohort study used data from the National Health Insurance Service sample cohort in South Korea. Patients aged ≥ 50 years who were hospitalized for osteoporotic fractures, including surgically and conservatively managed cases, between 2007 and 2019, were included. The primary exposure was receipt of osteoporosis medication during hospitalization, and the primary outcome was medication continuation within 1 year post-discharge. Log-binomial regression models were used to estimate adjusted risk ratios (aRRs) for post-discharge medication continuation, adjusted for demographic, socioeconomic, and clinical variables. Subgroup analyses were conducted by age, sex, fracture site, income level, and residential region. Results: Of 19,021 patients with osteoporotic fractures, 25.9% received osteoporosis treatment during hospitalization. The 1-year post-discharge medication rate was 75.8% in the treatment group, compared to 25.4% in the non-treatment group. The aRR for post-discharge medication continuation was 2.23 (95% CI, 2.14-2.32). Similar effects were observed for both oral (aRR, 2.26) and injectable (aRR, 2.13) medications. Subgroup analysis revealed stronger associations in males (aRR, 5.01), younger patients (50-70 years; aRR, 2.93), and those with minor fractures (aRR, 3.22). Although the overall continuation rate was lower in older adults and patients with major fractures, in-hospital treatment was still positively associated with improved adherence. Conclusions: In-hospital initiation of osteoporosis medication was associated with improved post-discharge treatment continuity in patients with osteoporotic fractures. Incorporating structured osteoporosis management into inpatient orthopedic care pathways may help enhance long-term adherence and support secondary fracture prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.